Background: PSMA-PET imaging may refine salvage radiotherapy targeting in recurrent prostate cancer. Methods: Prospective study of 280 patients with BCR post-prostatectomy undergoing PSMA-PET guided vs. conventional salvage RT. PSA outcomes at 24 months. Results: PSA undetectable rate: PSMA-guided 68.4% vs. conventional 48.2% (p<0.001). Metastasis-free survival improved (HR 0.62, p=0.008). Treatment volumes modified in 72% of PSMA-guided patients. Conclusion: PSMA-PET guidance significantly improves salvage RT outcomes in biochemically recurrent prostate cancer through precise treatment targeting
For any inquiries regarding the journal, publication process, or manuscript status, please contact the Editorial Office at support@cjcpt.org.
Authors are requested to submit their manuscripts and related documents via email at submission@cjcpt.org
Please contact us on WhatsApp: https://wa.me/447460013985